Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome
- Autores
- Russo, Matias Irineo; Márquez, María Antonela; Andrada, Lidia Estefania; Gauffin Cano, María Paola; Medina, Roxana Beatriz
- Año de publicación
- 2022
- Idioma
- inglés
- Tipo de recurso
- documento de conferencia
- Estado
- versión publicada
- Descripción
- Metabolic syndrome (MS) is one of the most relevant health problems in the world due to increased consumption of high-fat diets and the consequent obesity. MS is a cluster of cardio-metabolic risk factors and comorbidities conveying high risk of both cardiovascular disease and type 2 diabetes. Comorbidities associated with MS include proinflammatory state, prothrombotic state, nonalcoholic fatty liver disease. Lactobacillus johnsonii CRL1231 (Lj) is a strain with feruloyl esterase activity which increases the release of ferulic acid (FA) in the intestine and improves the biomarkers of MS. When the AF esterified in bran fibers is released, it can exert its lipid-lowering effect. The objective of this work was to evaluate the effect of oral administration of Lj on accumulation of abdominal and hepatic fat, and inflammatory state of mice with MS induced by a high-fat diet supplemented with wheat bran (HFD+WB). Male six-week-old Swiss albino mice (n = 24) were fed for 14 weeks; they were divided into 3 groups: Control group: mice received water and normal diet; MS group: mice received water and HFD+WB; MS+Lj group: mice received suspension of Lj (dose: 108 CFU / day / mouse) and HFD+WB. The adiposity index (AI) was calculated: AI = [Fat weight / Body weight] x 100. Histopathological analysis of liver and epididymal adipose tissue (evaluation of adipocyte area) was performed. Plasma levels of AST and ALT transaminases were measured by enzymatic methods and leptin levels by immunoassay. Cytokine levels (TNF-α, IFN-γ, IL-6 and IL-10) were determined by flow cytometry. The AI was 2 times higher in MS group compared to Control group, and decreased 30% in MS+Lj group compared to MS group. Abundance of large adipocytes (4000-8000 μm2) was 9% in Control group, 57% in MS group, and it was reduced to 20% in MS+Lj group. Plasma leptin levels were 7 times higher in MS group than in Control group, and 2 times lower in MS+Lj group with respect to MS group. The levels of pro-inflammatory cytokines (TNF-α, IFN-γ, IL-6) increased in MS group compared to Control group, and decreased in MS+Lj group. The levels of anti-inflammatory IL-10 were reduced 3 times in MS group compared to Control group, but an increase of 2 times was evidenced in the MS+Lj group. Liver histology revealed steatosis in the MS group and showed a reduction in fatty infiltration in hepatocytes of the MS+Lj group. Increased levels of ALT and AST are often associated with liver damage resulting from unhealthy habits, such as a high-fat diet. Results showed that ALT and AST levels increased 2 times in MS group with respect to Control group, while MS+Lj group did not show significant differences with the Control group. According to the results obtained in this work, oral administration of Lj reduces AI, prevents hypertrophy of adipose tissue, decreases hyperleptinemia, and improves the inflammatory profile and steatosis in mice with MS fed HFD+WB.
Fil: Russo, Matias Irineo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: Márquez, María Antonela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: Andrada, Lidia Estefania. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: Gauffin Cano, María Paola. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: Medina, Roxana Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
LVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General Microbiology
Ciudad Autónoma de Buenos Aires
Argentina
Sociedad Argentina de Investigación Bioquímica y Biología Molecular
Sociedad Argentina de Microbiología General - Materia
-
BACTERIAS LACTICAS
PROBIOTICOS
SINDROME METABOLICO - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/263344
Ver los metadatos del registro completo
id |
CONICETDig_8f6a1f5d97dd26164d86836b72ee8c1b |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/263344 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndromeRusso, Matias IrineoMárquez, María AntonelaAndrada, Lidia EstefaniaGauffin Cano, María PaolaMedina, Roxana BeatrizBACTERIAS LACTICASPROBIOTICOSSINDROME METABOLICOhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Metabolic syndrome (MS) is one of the most relevant health problems in the world due to increased consumption of high-fat diets and the consequent obesity. MS is a cluster of cardio-metabolic risk factors and comorbidities conveying high risk of both cardiovascular disease and type 2 diabetes. Comorbidities associated with MS include proinflammatory state, prothrombotic state, nonalcoholic fatty liver disease. Lactobacillus johnsonii CRL1231 (Lj) is a strain with feruloyl esterase activity which increases the release of ferulic acid (FA) in the intestine and improves the biomarkers of MS. When the AF esterified in bran fibers is released, it can exert its lipid-lowering effect. The objective of this work was to evaluate the effect of oral administration of Lj on accumulation of abdominal and hepatic fat, and inflammatory state of mice with MS induced by a high-fat diet supplemented with wheat bran (HFD+WB). Male six-week-old Swiss albino mice (n = 24) were fed for 14 weeks; they were divided into 3 groups: Control group: mice received water and normal diet; MS group: mice received water and HFD+WB; MS+Lj group: mice received suspension of Lj (dose: 108 CFU / day / mouse) and HFD+WB. The adiposity index (AI) was calculated: AI = [Fat weight / Body weight] x 100. Histopathological analysis of liver and epididymal adipose tissue (evaluation of adipocyte area) was performed. Plasma levels of AST and ALT transaminases were measured by enzymatic methods and leptin levels by immunoassay. Cytokine levels (TNF-α, IFN-γ, IL-6 and IL-10) were determined by flow cytometry. The AI was 2 times higher in MS group compared to Control group, and decreased 30% in MS+Lj group compared to MS group. Abundance of large adipocytes (4000-8000 μm2) was 9% in Control group, 57% in MS group, and it was reduced to 20% in MS+Lj group. Plasma leptin levels were 7 times higher in MS group than in Control group, and 2 times lower in MS+Lj group with respect to MS group. The levels of pro-inflammatory cytokines (TNF-α, IFN-γ, IL-6) increased in MS group compared to Control group, and decreased in MS+Lj group. The levels of anti-inflammatory IL-10 were reduced 3 times in MS group compared to Control group, but an increase of 2 times was evidenced in the MS+Lj group. Liver histology revealed steatosis in the MS group and showed a reduction in fatty infiltration in hepatocytes of the MS+Lj group. Increased levels of ALT and AST are often associated with liver damage resulting from unhealthy habits, such as a high-fat diet. Results showed that ALT and AST levels increased 2 times in MS group with respect to Control group, while MS+Lj group did not show significant differences with the Control group. According to the results obtained in this work, oral administration of Lj reduces AI, prevents hypertrophy of adipose tissue, decreases hyperleptinemia, and improves the inflammatory profile and steatosis in mice with MS fed HFD+WB.Fil: Russo, Matias Irineo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaFil: Márquez, María Antonela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaFil: Andrada, Lidia Estefania. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaFil: Gauffin Cano, María Paola. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaFil: Medina, Roxana Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaLVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General MicrobiologyCiudad Autónoma de Buenos AiresArgentinaSociedad Argentina de Investigación Bioquímica y Biología MolecularSociedad Argentina de Microbiología GeneralTech Science Press2022info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectReuniónJournalhttp://purl.org/coar/resource_type/c_5794info:ar-repo/semantics/documentoDeConferenciaapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/263344Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome; LVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General Microbiology; Ciudad Autónoma de Buenos Aires; Argentina; 2021; 103-1040327-95451667-5746CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.techscience.com/biocell/v46nSuppl.1Internacionalinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:09:56Zoai:ri.conicet.gov.ar:11336/263344instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:09:57.175CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome |
title |
Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome |
spellingShingle |
Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome Russo, Matias Irineo BACTERIAS LACTICAS PROBIOTICOS SINDROME METABOLICO |
title_short |
Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome |
title_full |
Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome |
title_fullStr |
Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome |
title_full_unstemmed |
Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome |
title_sort |
Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome |
dc.creator.none.fl_str_mv |
Russo, Matias Irineo Márquez, María Antonela Andrada, Lidia Estefania Gauffin Cano, María Paola Medina, Roxana Beatriz |
author |
Russo, Matias Irineo |
author_facet |
Russo, Matias Irineo Márquez, María Antonela Andrada, Lidia Estefania Gauffin Cano, María Paola Medina, Roxana Beatriz |
author_role |
author |
author2 |
Márquez, María Antonela Andrada, Lidia Estefania Gauffin Cano, María Paola Medina, Roxana Beatriz |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
BACTERIAS LACTICAS PROBIOTICOS SINDROME METABOLICO |
topic |
BACTERIAS LACTICAS PROBIOTICOS SINDROME METABOLICO |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Metabolic syndrome (MS) is one of the most relevant health problems in the world due to increased consumption of high-fat diets and the consequent obesity. MS is a cluster of cardio-metabolic risk factors and comorbidities conveying high risk of both cardiovascular disease and type 2 diabetes. Comorbidities associated with MS include proinflammatory state, prothrombotic state, nonalcoholic fatty liver disease. Lactobacillus johnsonii CRL1231 (Lj) is a strain with feruloyl esterase activity which increases the release of ferulic acid (FA) in the intestine and improves the biomarkers of MS. When the AF esterified in bran fibers is released, it can exert its lipid-lowering effect. The objective of this work was to evaluate the effect of oral administration of Lj on accumulation of abdominal and hepatic fat, and inflammatory state of mice with MS induced by a high-fat diet supplemented with wheat bran (HFD+WB). Male six-week-old Swiss albino mice (n = 24) were fed for 14 weeks; they were divided into 3 groups: Control group: mice received water and normal diet; MS group: mice received water and HFD+WB; MS+Lj group: mice received suspension of Lj (dose: 108 CFU / day / mouse) and HFD+WB. The adiposity index (AI) was calculated: AI = [Fat weight / Body weight] x 100. Histopathological analysis of liver and epididymal adipose tissue (evaluation of adipocyte area) was performed. Plasma levels of AST and ALT transaminases were measured by enzymatic methods and leptin levels by immunoassay. Cytokine levels (TNF-α, IFN-γ, IL-6 and IL-10) were determined by flow cytometry. The AI was 2 times higher in MS group compared to Control group, and decreased 30% in MS+Lj group compared to MS group. Abundance of large adipocytes (4000-8000 μm2) was 9% in Control group, 57% in MS group, and it was reduced to 20% in MS+Lj group. Plasma leptin levels were 7 times higher in MS group than in Control group, and 2 times lower in MS+Lj group with respect to MS group. The levels of pro-inflammatory cytokines (TNF-α, IFN-γ, IL-6) increased in MS group compared to Control group, and decreased in MS+Lj group. The levels of anti-inflammatory IL-10 were reduced 3 times in MS group compared to Control group, but an increase of 2 times was evidenced in the MS+Lj group. Liver histology revealed steatosis in the MS group and showed a reduction in fatty infiltration in hepatocytes of the MS+Lj group. Increased levels of ALT and AST are often associated with liver damage resulting from unhealthy habits, such as a high-fat diet. Results showed that ALT and AST levels increased 2 times in MS group with respect to Control group, while MS+Lj group did not show significant differences with the Control group. According to the results obtained in this work, oral administration of Lj reduces AI, prevents hypertrophy of adipose tissue, decreases hyperleptinemia, and improves the inflammatory profile and steatosis in mice with MS fed HFD+WB. Fil: Russo, Matias Irineo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina Fil: Márquez, María Antonela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina Fil: Andrada, Lidia Estefania. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina Fil: Gauffin Cano, María Paola. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina Fil: Medina, Roxana Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina LVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General Microbiology Ciudad Autónoma de Buenos Aires Argentina Sociedad Argentina de Investigación Bioquímica y Biología Molecular Sociedad Argentina de Microbiología General |
description |
Metabolic syndrome (MS) is one of the most relevant health problems in the world due to increased consumption of high-fat diets and the consequent obesity. MS is a cluster of cardio-metabolic risk factors and comorbidities conveying high risk of both cardiovascular disease and type 2 diabetes. Comorbidities associated with MS include proinflammatory state, prothrombotic state, nonalcoholic fatty liver disease. Lactobacillus johnsonii CRL1231 (Lj) is a strain with feruloyl esterase activity which increases the release of ferulic acid (FA) in the intestine and improves the biomarkers of MS. When the AF esterified in bran fibers is released, it can exert its lipid-lowering effect. The objective of this work was to evaluate the effect of oral administration of Lj on accumulation of abdominal and hepatic fat, and inflammatory state of mice with MS induced by a high-fat diet supplemented with wheat bran (HFD+WB). Male six-week-old Swiss albino mice (n = 24) were fed for 14 weeks; they were divided into 3 groups: Control group: mice received water and normal diet; MS group: mice received water and HFD+WB; MS+Lj group: mice received suspension of Lj (dose: 108 CFU / day / mouse) and HFD+WB. The adiposity index (AI) was calculated: AI = [Fat weight / Body weight] x 100. Histopathological analysis of liver and epididymal adipose tissue (evaluation of adipocyte area) was performed. Plasma levels of AST and ALT transaminases were measured by enzymatic methods and leptin levels by immunoassay. Cytokine levels (TNF-α, IFN-γ, IL-6 and IL-10) were determined by flow cytometry. The AI was 2 times higher in MS group compared to Control group, and decreased 30% in MS+Lj group compared to MS group. Abundance of large adipocytes (4000-8000 μm2) was 9% in Control group, 57% in MS group, and it was reduced to 20% in MS+Lj group. Plasma leptin levels were 7 times higher in MS group than in Control group, and 2 times lower in MS+Lj group with respect to MS group. The levels of pro-inflammatory cytokines (TNF-α, IFN-γ, IL-6) increased in MS group compared to Control group, and decreased in MS+Lj group. The levels of anti-inflammatory IL-10 were reduced 3 times in MS group compared to Control group, but an increase of 2 times was evidenced in the MS+Lj group. Liver histology revealed steatosis in the MS group and showed a reduction in fatty infiltration in hepatocytes of the MS+Lj group. Increased levels of ALT and AST are often associated with liver damage resulting from unhealthy habits, such as a high-fat diet. Results showed that ALT and AST levels increased 2 times in MS group with respect to Control group, while MS+Lj group did not show significant differences with the Control group. According to the results obtained in this work, oral administration of Lj reduces AI, prevents hypertrophy of adipose tissue, decreases hyperleptinemia, and improves the inflammatory profile and steatosis in mice with MS fed HFD+WB. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/conferenceObject Reunión Journal http://purl.org/coar/resource_type/c_5794 info:ar-repo/semantics/documentoDeConferencia |
status_str |
publishedVersion |
format |
conferenceObject |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/263344 Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome; LVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General Microbiology; Ciudad Autónoma de Buenos Aires; Argentina; 2021; 103-104 0327-9545 1667-5746 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/263344 |
identifier_str_mv |
Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome; LVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General Microbiology; Ciudad Autónoma de Buenos Aires; Argentina; 2021; 103-104 0327-9545 1667-5746 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.techscience.com/biocell/v46nSuppl.1 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.coverage.none.fl_str_mv |
Internacional |
dc.publisher.none.fl_str_mv |
Tech Science Press |
publisher.none.fl_str_mv |
Tech Science Press |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613983509676032 |
score |
13.070432 |